Antimicrobials Flashcards
Four classes of beta lactams
Penicillins
Monobactams
Cephalosporins
Carbapenems
Narrow spectrum penicillins
Penicillin is mainly used for the treatment of Gram-positive pathogens such as streptococci, enterococci and anaerobes such as Clostridium spp
Phenoxymethylpenicllin V, oral
Benzylpenicillin, penicillin G, IV
Benzathine penicillin, IM, IV in system for 4 weeks
Procaine penicillin, IV
Anti-staphylcoccal penicillins
Members include: flucloxacillin, dicloxacillin. These drugs are stable to beta - lactamase produced by staphylococci and are therefore particularly useful against most strains of S. aureus.
Moderate spectrum penicillins
These agents, the aminopenicillins (amoxycillin and ampicillin), have greater activity than benzylpenicillin against common Gram-negative pathogens such as E. coli and H.influenzae.
Among patients with acute Epstein Barr virus infection (glandular fever), both drugs are similarly associated with the production of a prominent erythematous rash - however this does not indicate true allergy.
Broad spectrum antibiotics
Piperacillin and ticarcillin are active against Pseudomonas aeruginosa, but are generally administered in combination with a second anti-pseudomonal drug such an aminoglycoside.
Ticarcillin is generally inferior to piperacillin in its coverage of Klebsiella species, as well as enterococci. Both drugs are reasonably expensive, especially piperacillin.
Penicillin/beta-lactamase inhibitor combinations
amoxycillin (amoxycillin + clavulanate; Augmentin®)
ticarcillin (ticarcillin + clavulanate; Timentin®)
piperacillin (piperacillin + tazobactam; Tazocin®)
These have extended the spectrum of these drugs to include activity against S. aureus, anaerobes (e.g. B. fragilis) and strains of Gram-negative pathogens such as E. coli, Neisseria gonorrhoea and H. influenzae that are resistant to each of these penicillins alone.
First generation cephalosporins
Cephalothin
Cephazolin
Cephalexin
Good gram positive activity
Gram negative activity against enterobacteriacae, klebsiella
Second generation cephalosporins
Cefaclor and cefuroxime
Cefoxitin and cefotetan
Good gram positive cover
Improved gram negative cover, covers haemophilus, enterbacteriacae, klebsiella
Only cephalosporin group to cover anaerobes
Third generation cephalosporins
Cefotaxime and ceftriaxone
Ceftazidime
No MSSA cover
Ceftazidime does not cover MSSA or streptococci
Cefotaxime and ceftriaxone will have good gram negative coverage as does second generation
Ceftazidime will cover pseudomonas
Fourth generation cephalosporins
cefepime and cefpirome
Wider coverage than third generation
Will cover most gram positives including MSSA
Will cover most gram negatives including pseudomonas and ESCAPPM group
Fifth generation cephalosporin
Ceftaroline
MRSA and penicillin non-susceptible Strept. pneumoniae activity (PNSP)
Wide gram negative and gram positive activity
Carbapenems
Meropenem, ertapenem and imipenem
Action on wide spectrum of gram positive and negative bacteria
pseudomonas, ESCAPPMs, MRSA, Burkholderia cepacia and Stenotrophomonas maltophilia.
Meropenem has good CSF penetration
Glycopeptides
Vancomycin and Teicoplanin
Glycopeptides include vancomycin and teicoplanin, both of which are active against a wide range of Gram-positive organisms including MRSA and methicillin-resistant S. epidermidis (MRSE).
Aminoglycosides
Aminoglycosides (gentamicin, tobramycin, netilmicin, amikacin, streptomycin, neomycin and framycetin) are active against most Gram-negative pathogens including Pseudomonas aeruginosa, but have no substantive Grampositive activity as monotherapy.
Macrolides
Macrolides include erythromycin, roxithromycin, azithromycin and clarithromycin. They have a wide spectrum of activity including Gram-positive cocci such as streptococci and staphylococci, as well as so-called “atypical” pathogens such as Legionella, Mycoplasma and Chlamydia spp.
They are also active against Bordetella pertussis (whooping cough), Corynebacteria and some strains of H. influenzae. Notably, they have no activity against enteric Gram-negative bacilli and resistance among S. pneumoniae and S. aureus is increasing.
Azithromycin and clarithromycin are newer agents and have longer half lives
Clarithromycin has Mycobacterium avium activity